NEW YORK, Oct. 4, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced that the Company and its wholly-owned subsidiary, Progenitor Cell Therapy ("PCT"), will be presenting at three upcoming October conferences: the 2011 World Stem Cell Summit, the AABB Annual Meeting & CTTXPO, and Cell Therapy Bioprocessing.
2011 World Stem Cell Summit – October 3-5, 2011, Pasadena, California – Convention Center
3:45 PM on Tuesday, October 4 - Jason Kolbert, NeoStem's VP of Strategic Business Development, will moderate an industry session entitled "The Paradigm Shift to Cell Based Medicine: How Investors Can Discern True Value."
12 PM on Wednesday, October 5 - Dr. Robin L. Smith, Chairman and CEO of NeoStem, Inc. will also speak at the World Stem Cell Summit in an industry session entitled "Financing Pathways for Stem Companies and Novel Funding Options."
AABB Annual Meeting & CTTXPO – October 22-25, 2011, San Diego, California – San Diego Convention Center
10:30 AM on Saturday, October 22 - Robert A. Preti, PhD, President and Chief Scientific Officer of PCT, will speak on a panel entitled "Cellular Therapy Product Development Using Project Management Techniques."
Cell Therapy Bioprocessing – October 17-18, 2011, Reston, Virginia – Hyatt Regency Reston
11:15 AM on Monday, October 17 - Karen Trujillo, BSc, Director of the Mountain View Facility for PCT, will give a presentation on the "Development of Lot Release Assays During Product Development."
Dr. Robin L. Smith said, "We are delighted to participate in this significant conference. In addition to sharing our knowledge of the industry, we con
|SOURCE NeoStem, Inc.|
Copyright©2010 PR Newswire.
All rights reserved